Spark’s novel gene therapy for blindness is racing to a historic date with the FDA – STAT
STAT |
Spark's novel gene therapy for blindness is racing to a historic date with the FDA
STAT On Thursday, a committee of experts invited by the FDA will meet outside Washington D.C. to review an experimental gene therapy from Spark Therapeutics (ONCE 1). Barring unexpected surprises, the experts will advise the FDA to approve the one-time shot … |
